Related Experiment Video
Updated: May 8, 2026
07:58
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
Molecular signatures in urologic tumors
Spencer Larkin1, Natasha Kyprianou
1Departments of Urology, University of Kentucky College of Medicine, Lexington, Kentucky, KY 40536, USA. nkypr2@uky.edu.
International Journal of Molecular Sciences
|September 11, 2013
Summary
Molecular signatures offer promising tools for diagnosing urologic cancers and predicting treatment response. This review explores their clinical value in identifying the pathological aggressiveness of prostate, bladder, and renal tumors.
Area of Science:
- Oncology
- Genomics
- Personalized Medicine
Background:
- Urologic tumors account for a significant number of cancer diagnoses.
- Tumor phenotypes vary widely, from minimally invasive to highly metastatic.
- Current detection and severity prediction methods are often invasive and lack reliability.
Purpose of the Study:
- To review the literature on molecular signatures for urologic malignancies.
- To assess the biomarker value and clinical significance of these signatures.
- To explore their predictive potential in treatment response.
Main Methods:
- Review of current scientific literature on molecular signatures.
- Analysis of gene cluster panels for diagnostic and prognostic applications.
- Evaluation of clinical significance in relation to pathological aggressiveness.
Main Results:
- Molecular signatures show potential for improved diagnosis and severity prediction.
- Biomarker value is being established for various urologic tumors.
- Predictive capabilities for treatment response are under investigation.
Conclusions:
- Molecular signatures are crucial for advancing personalized medicine in urology.
- Further research is needed to fully integrate these tools into clinical practice.
- These signatures hold promise for more effective and targeted cancer therapies.
